Elite Pharmaceuticals, Inc.
ELTP·28659T200·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic
ELTP (Elite Pharmaceuticals, Inc.) is held by 0 institutional investors as of Q4 2023.
0
Holders
(1 Elite)
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Oct 3, 2025 · Activists none · Congress none
InsiderPDPlassche DouglasSell $499KOct 2, 2025
InsiderE/ELITE PHARMACEUTICALS INC /NV/Sell $262KAug 22, 2025
InsiderKKKirkov KirkoBuy $10KJul 10, 2025
Checking access…
Top Holders
Checking access…
Fund | Action | Shares | Value | Weight | Est. P&L | Conviction |
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $7,693 | 0.0% | +55.56% | 0 |
ELTPElite Pharmaceuticals, Inc.Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO403 holders · $856.6B
UNHUNITEDHEALTH GROUP INC403 holders · $286.8B
TMOTHERMO FISHER SCIENTIFIC INC388 holders · $148B
JNJJOHNSON & JOHNSON385 holders · $405.5B
DHRDANAHER CORP384 holders · $95B
ISRGINTUITIVE SURGICAL INC381 holders · $105.8B
MRKMERCK & CO. INC.378 holders · $226B
BSXBOSTON SCIENTIFIC CORP375 holders · $51.2B
ABBVABBVIE INC373 holders · $296.3B
ABTABBOTT LABORATORIES371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer